Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation

S Nattel - JACC: Clinical Electrophysiology, 2017 - jacc.org
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Atrial fibrosis has
emerged as an important pathophysiological contributor and has been linked to AF …

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

J Andrade, P Khairy, D Dobrev, S Nattel - Circulation research, 2014 - Am Heart Assoc
Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%–26%). The
aim of this article is to review the clinical epidemiological features of AF and to relate them to …

Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease

RG Gourdie, S Dimmeler, P Kohl - Nature reviews Drug discovery, 2016 - nature.com
Our understanding of the functions of cardiac fibroblasts has moved beyond their roles in
heart structure and extracellular matrix generation and now includes their contributions to …

Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review

AC Ernault, VMF Meijborg, R Coronel - Journal of the American College of …, 2021 - jacc.org
Obesity is a significant risk factor for arrhythmic cardiovascular death. Interactions between
epicardial adipose tissue (EAT) and myocytes are thought to play a key role in the …

Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation

L Yue, J Xie, S Nattel - Cardiovascular research, 2011 - academic.oup.com
Cardiac fibroblasts account for about 75% of all cardiac cells, but because of their small size
contribute only∼ 10–15% of total cardiac cell volume. They play a crucial role in cardiac …

[HTML][HTML] Atrial fibrillation: mechanisms, therapeutics, and future directions

J Pellman, F Sheikh - Comprehensive Physiology, 2015 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting 1% to 2% of the
general population. It is characterized by rapid and disorganized atrial activation leading to …

Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems

J Pellman, J Zhang, F Sheikh - Journal of molecular and cellular cardiology, 2016 - Elsevier
Abstract Development of cardiac fibrosis and arrhythmias is controlled by the activity of and
communication between cardiomyocytes and fibroblasts in the heart. Myocyte-fibroblast …

Mechanosensing dysregulation in the fibroblast: a hallmark of the aging heart

A Angelini, JA Trial, J Ortiz-Urbina, KA Cieslik - Ageing research reviews, 2020 - Elsevier
The myofibroblast is a specialized fibroblast that expresses α-smooth muscle actin (α-SMA)
and participates in wound contraction and fibrosis. The fibroblast to myofibroblast transition …

Personalized cardiac computational models: from clinical data to simulation of infarct-related ventricular tachycardia

A Lopez-Perez, R Sebastian, M Izquierdo… - Frontiers in …, 2019 - frontiersin.org
In the chronic stage of myocardial infarction, a significant number of patients develop life-
threatening ventricular tachycardias (VT) due to the arrhythmogenic nature of the remodeled …

OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology

A Klimas, CM Ambrosi, J Yu, JC Williams… - Nature …, 2016 - nature.com
The improvement of preclinical cardiotoxicity testing, discovery of new ion-channel-targeted
drugs, and phenotyping and use of stem cell-derived cardiomyocytes and other biologics all …